Dashi pharmaceutical completed a round of financing of nearly 100 million yuan
On August 31, Dashi pharmaceutical announced that it had recently completed a round of financing of nearly 100 million yuan. This round of financing was led by Kaitai capital, and pre-A round of investors Shenzhen sharing investment and Zhongshan Xiangshang investment continued to participate in this round of financing. The funds obtained in this round of financing will be mainly used to promote the phase 1 and phase 2A clinical research and development of the company's first non addictive long-acting analgesic ds002. In addition, it will also be used to enrich the company's R & D pipeline, build CMC pilot platform, expand talent team and other company operation needs.
This text is a result of machine translation.
Briefing Updated 8 hours ago
· Healthcare
Nuoyi Mayer completed a round of 100 million yuan a + + financing and deeply laid out multiple implantable medical device product pipelines
Briefing Oct 20, 2021 09:19 AM
· Healthcare
Kangyuan obtained tens of millions of yuan of round a financing for a long time and accelerated the application of jy108 dual anti drug ind
In depth
Healthcare
Bid for Molecular Tech in China's Early-Stage Cancer Detection Market
China, with a population of 1.4 billion, has one of the largest gene pools in the world. How does its DNA tech-based cancer detection industry look? Listed on Nasdaq in 2020, Genetron Holdings Limited (Genetron Health) is taking a leading role.
Sep 09, 2020 03:08 PM
Briefing Oct 19, 2021 10:21 AM
· Healthcare
Microchip diabetes mellitus new drug glipizide sodium approved in China
Briefing Oct 15, 2021 05:24 PM
· Healthcare
New drugs will be on the shelves in three days at the fastest, and Ali health pharmacy starts the "new drug launch support plan"
Apr 22, 2021 03:11 PM
Research
Consumer Staples, Technology, HealthcareWIA2020 | Rising Tech Stars 2020: Global & China's 100
Dec 09, 2020 09:57 AM
Dec 09, 2020 09:39 AM
Aug 09, 2020 12:23 AM
Briefing Oct 08, 2021 10:27 AM
· Healthcare
Yiyi biological submitted ryzneuta to the European drug administration ™ Listing application accepted
Briefing Oct 05, 2021 09:50 AM
· Healthcare
After the layout of gene therapy track, Takeda reached a cooperation with selecta for more than US $1.1 billion
Briefing Sep 30, 2021 02:41 PM
· Healthcare
AstraZeneca acquires Caelum Biosciences overweight rare diseases business
Briefing Sep 29, 2021 08:46 PM
· Healthcare
Randomized trials show that whole genome sequencing is helpful to improve the nursing of critically ill infants in different situations
Briefing Sep 27, 2021 11:57 AM
· Healthcare
Triarm therapeutics completed a round of financing of US $60 million
Briefing Sep 26, 2021 03:01 PM
· Healthcare
Boehringer Ingelheim joins hands with Meixin health and Yuanxin technology to create an ecosystem for the management of the whole course of patients
Briefing Sep 25, 2021 09:49 PM
· Healthcare
Zhongkang technology and Huawei cloud strategic cooperation to accelerate the digital intelligence process of the pharmaceutical and health industry
Insight
Briefing Sep 24, 2021 11:23 AM
· Healthcare
The new Kangtaike is rejuvenated and loves to be fully opened
Briefing Sep 18, 2021 09:08 AM
· Healthcare
Puri benchmark obtained 150 million yuan of round B financing to promote the research and development of new drugs driven by multi omics data mining
Briefing Sep 15, 2021 05:03 PM
· Healthcare
Focusing on digital human imaging solutions, Shukun technology, a medical AI enterprise, launched its IPO in Hong Kong
See more
Read next
Automotive · Analysis
Volkswagen's EVs Are Taking Off in China, May Soon Surpass NIO's Market Share
Yesterday 02:08 PM
In depth
Consumer Staples, Consumer Discretionary
What's 'New' about the New Consumer Brands in China?
Oct 19, 2021 10:15 AM
Technology · Analysis
SMIC, China's Rising TSMC Competitor, Makes a Strategic Business U-Turn
Oct 18, 2021 04:46 PM
In depth
Technology
China Chips: Will China Dominate the World Semiconductor Market in 5 Years? [1/2]
Oct 18, 2021 03:14 PM
EqualOcean is an information service provider and investment research company that aims to become a global platform for industrial innovation. Founded in February 2014 and headquartered in Beijing, with a client network covering over 50 countries, the firm provides comprehensive professional services, including industry research, investment analysis, innovation consulting, data products, corporate branding and international strategy.